Literature DB >> 18175121

Dynamic contrast-enhanced MRI in Paget's disease of bone--correlation of regional microcirculation and bone turnover.

M Libicher1, C Kasperk, M Daniels, W Hosch, H-U Kauczor, S Delorme.   

Abstract

The purpose of this study was to evaluate regional microcirculation in Paget's disease of bone (PD) with dynamic contrast-enhanced MR imaging (DCE-MRI). Additionally, we correlated regional bone perfusion with alkaline phosphatase as serum marker of bone turnover. We examined 71 patients with PD (27 men, 44 women, 67+/-10 years) localized at the axial and appendicular skeleton. Contrast uptake was analyzed using a two-compartment model with the output variables amplitude A and exchange rate constant k(ep). Color-coded parametric images were generated to visualize microcirculation. Serum levels of alkaline phosphatase (AP) were compared with DCE-MRI parameters. Amplitude A and exchange rate constant k(ep) were significantly increased in PD compared to unaffected bone (A(PD) 0.81+/-0.24 vs. A(control) 0.34+/-0.1 and k(ep PD) 4.0+/-2.86 vs. k(ep control) 1.73+/-0.88, p<0.001). There was a significant correlation (r(s)=0.5-0.7) of DCE-MRI parameters and AP at the axial (pelvis, spine) and appendicular skeleton (femur, tibia). The long bones showed increased circulation of the advancing peripheral zones and no vascularization of the central part, which had been replaced by fatty tissue. Regional microcirculation in PD is inhomogeneous with focal areas of excessive hypervascularity, especially in the advancing peripheral zone. There is a significant correlation of bone circulation and bone turnover in PD. DCE-MRI might therefore be a diagnostic tool for monitoring therapeutic effects of bisphosphonates in Paget's disease of bone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175121     DOI: 10.1007/s00330-007-0837-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  27 in total

1.  Digital subtraction angiography demonstration of bone hypervascularity in Paget's disease.

Authors:  R Loneragan
Journal:  Australas Radiol       Date:  1999-05

2.  Paget's disease of bone is characterized by excessive bone resorption coupled with excessive and disorganized bone formation.

Authors:  D C Anderson
Journal:  Bone       Date:  2001-09       Impact factor: 4.398

3.  The blade of grass sign.

Authors:  K Wittenberg
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

Review 4.  From the archives of the AFIP. Radiologic spectrum of Paget disease of bone and its complications with pathologic correlation.

Authors:  Stacy E Smith; Mark D Murphey; Kambiz Motamedi; Michael E Mulligan; Charles S Resnik; Francis H Gannon
Journal:  Radiographics       Date:  2002 Sep-Oct       Impact factor: 5.333

5.  [Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma].

Authors:  K Wasser; T Moehler; S Nosas-Garcia; C Rehm; R Bartl; H Goldschmidt; C Düber; H U Kauczor; S Delorme
Journal:  Rofo       Date:  2005-08

6.  Endothelin-1 levels in patients with Paget's disease of bone.

Authors:  R Pirzer; N Tilly; U Sommer; U Liegibel; I Grafe; P Nawroth; C Kasperk
Journal:  Exp Clin Endocrinol Diabetes       Date:  2005-12       Impact factor: 2.949

7.  Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.

Authors:  Jens Hillengass; Klaus Wasser; Stefan Delorme; Fabian Kiessling; Christian Zechmann; Axel Benner; Hans-Ulrich Kauczor; Anthony D Ho; Hartmut Goldschmidt; Thomas M Moehler
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

8.  Evaluation of angiogenesis and perfusion of bone marrow lesions: role of semiquantitative and quantitative dynamic MRI.

Authors:  H Hawighorst; M Libicher; M V Knopp; T Moehler; G W Kauffmann; G v Kaick
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

Review 9.  Skeletal blood flow in Paget's disease of bone.

Authors:  R Wootton; M Tellez; J R Green; J Reeve
Journal:  Metab Bone Dis Relat Res       Date:  1981

10.  Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging.

Authors:  T M Moehler; H Hawighorst; K Neben; G Egerer; J Hillengass; R Max; A Benner; A D Ho; G van Kaick; H Goldschmidt
Journal:  Int J Cancer       Date:  2001-09       Impact factor: 7.396

View more
  6 in total

1.  Highlights of the European Society of Musculoskeletal Radiology (ESSR) annual meeting 2008.

Authors:  Andrew J Grainger
Journal:  Skeletal Radiol       Date:  2008-10-21       Impact factor: 2.199

2.  Bone vascularization and trabecular bone formation are mediated by PKB alpha/Akt1 in a gene-dosage-dependent manner: in vivo and ex vivo MRI.

Authors:  Katrien Vandoorne; Jeremy Magland; Vicki Plaks; Amnon Sharir; Elazar Zelzer; Felix Wehrli; Brian A Hemmings; Alon Harmelin; Michal Neeman
Journal:  Magn Reson Med       Date:  2010-07       Impact factor: 4.668

Review 3.  An update on imaging of Paget's sarcoma.

Authors:  William Tilden; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-01-02       Impact factor: 2.199

4.  Dynamic contrast-enhanced magnetic resonance imaging can assess vascularity within fracture non-unions and predicts good outcome.

Authors:  Oliver Schoierer; Konstantin Bloess; Daniel Bender; Iris Burkholder; Hans-Ulrich Kauczor; Gerhard Schmidmaier; Marc-André Weber
Journal:  Eur Radiol       Date:  2013-10-22       Impact factor: 5.315

5.  Dynamic contrast-enhanced MRI for monitoring bisphosphonate therapy in Paget's disease of bone.

Authors:  Martin Libicher; C Kasperk; M Daniels-Wredenhagen; T Heye; H U Kauczor; P Nawroth; S Delorme; W Hosch
Journal:  Skeletal Radiol       Date:  2012-05-16       Impact factor: 2.199

6.  Muscle-based pharmacokinetic modeling of marrow perfusion for osteoporotic bone in females.

Authors:  Heather Ting Ma; James F Griffth; Ping-Chung Leung
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.